# DEXLANSOPRAZOLE
> **ANDA202666** · Abbreviated New Drug Application (Generic) · Sponsor: TWI PHARMS · Approved 2022-09-16
## Drug
- **FDA Application Number:** ANDA202666
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEXLANSOPRAZOLE
- **Generic name:** DEXLANSOPRAZOLE
- **Active ingredients:** DEXLANSOPRAZOLE
- **Dosage form:** CAPSULE, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TWI PHARMS
- **Manufacturer:** Upsher-Smith Laboratories, LLC
- **First approval:** 2022-09-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202666)
---
*AI Analytics · CC0 1.0*